Welcome to our dedicated page for AI / ML Innovations news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML Innovations stock.
AI/ML Innovations Inc. (AIMLF) delivers cutting-edge artificial intelligence and machine learning solutions for digital health transformation. This page provides investors and industry professionals with essential updates about the company's strategic initiatives, regulatory milestones, and technological advancements.
Access comprehensive coverage of AIMLF's partnerships with Health Gauge Inc., AI Rx Inc., and other key players in healthcare technology. Track developments stemming from acquisitions like Quantum Sciences Ltd. and stay informed about operational updates across neural networks, cloud computing integrations, and precision healthcare platforms.
Key updates include: earnings reports, strategic investment announcements, regulatory filings, and leadership changes. Our curated news collection ensures you receive accurate information about the company's progress in developing AI-powered diagnostic tools and patient engagement systems.
Bookmark this page for verified updates about AIMLF's role in advancing machine learning applications for cardiovascular monitoring, neurodegenerative disorder management, and metabolic health solutions. Visit regularly to maintain current awareness of this innovator's evolving position in digital healthcare markets.
AI/ML Innovations Inc. has engaged Octagon Media Corp for a four-month marketing services agreement to support its digital media campaign. The agreement involves a payment of US$60,000, compensated through 800,000 common shares at CAD$0.10 each. Additionally, Octagon will receive options to purchase 300,000 shares at CAD$0.20. AI/ML focuses on AI and ML technologies for healthcare solutions, with investments in companies like Health Gauge and AI Rx Inc..
AI/ML Innovations Inc. has launched a warrant exercise incentive program to encourage the early exercise of up to 5,648,000 common share purchase warrants. This initiative aims to boost working capital through the exercise of Series 'B' and Series 'D' Warrants with repriced prices of $0.075 and $0.20, respectively. The early exercise period runs from December 19, 2022, to January 9, 2023. The company anticipates gross proceeds of up to $423,600 and plans to issue additional incentive warrants. The program requires approval from the Canadian Securities Exchange.
AI/ML Innovations Inc. (AIMLF) has announced the acquisition of the remaining 30% of Health Gauge Inc. (HGI) for 1,800,000 Incentive Warrants. AIML previously acquired 70% of HGI in August 2020, making this transaction significant for full ownership. The acquisition aligns with AIML's focus on advancing AI and machine learning in digital healthcare. The deal is subject to Exchange approval and aims to enhance AIML's capabilities in personal health monitoring systems.
AI/ML Innovations Inc. (CSE:AIML; OTCQB:AIMLF) announced that the British Columbia Securities Commission has lifted the Management Cease Trade Order (MCTO) previously imposed on August 30, 2022. This decision follows the successful completion of the required filings for its annual and interim financial statements. The MCTO had delayed the company's trading activities due to late filings associated with a significant equity investment in Tech2Heal SAS. The company expressed gratitude to its shareholders and regulators, ensuring its commitment to financial transparency.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced a delay in filing its financial documents, resulting in a management cease trade order (MCTO) from the British Columbia Securities Commission (BCSC) effective August 30, 2022. The CEO and CFO are restricted from trading until the annual audited financial statements are filed. The company aims to file the necessary documents by October 28, 2022, while addressing accounting issues related to a France-based investee. It will continue issuing bi-weekly default status reports during this period.
AI/ML Innovations Inc. announced that the British Columbia Securities Commission granted a management cease trade order (MCTO) affecting its CEO and CFO due to delays in filing required financial statements for the year ended April 30, 2022. The Company expects to file all necessary documents by October 28, 2022. The interim financial statements for the period ended July 31, 2022, also remain incomplete due to these delays. The Company will continue to provide bi-weekly updates during this period and is addressing accounting issues related to a France-based investee.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF, FWB:42FB) announced a management cease trade order (MCTO) from the British Columbia Securities Commission due to delays in filing annual financial statements for the fiscal year ended April 30, 2022. As a result, the company also missed the deadline for interim filings due September 29, 2022. The company aims to file the required documents by October 28, 2022, while continuing to issue bi-weekly default reports. Failure to comply may lead to a cease trade order on its securities.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced that the British Columbia Securities Commission (BCSC) granted a management cease trade order (MCTO) on August 30, 2022. This order prohibits the CEO and CFO from trading the company's securities until the filing of required audited financial statements for the year ending April 30, 2022. The company aims to file these documents by October 28, 2022, and will issue bi-weekly updates while in default. The MCTO does not hinder other shareholders from trading their securities.
AI/ML Innovations Inc. (CSE:AIML; OTCQB:AIMLF) announced its failure to file required audited annual financial statements for the year ending April 30, 2022, by the August 28, 2022 deadline, resulting in a default under National Instrument 51-102. The British Columbia Securities Commission has issued a management cease trade order (MCTO) which restricts insider trading but does not affect general shareholder trading. The company is actively working to rectify this situation and plans to complete required filings by October 28, 2022.
AI/ML Innovations Inc. (CSE:AIML; OTCQB:AIMLF) has applied for a Management Cease Trade Order (MCTO) from the British Columbia Securities Commission due to the inability to file audited financial statements by the deadline of August 28, 2022. The delays are attributed to the acquisition of Tech2Heal SAS and the need for additional financial documentation to comply with IFRS. The company expects to file the required documents by October 28, 2022. The MCTO, if granted, will restrict trading of shares by the CEO and CFO but will not affect general public trading.
FAQ
What is the current stock price of AI / ML Innovations (AIMLF)?
What is the market cap of AI / ML Innovations (AIMLF)?
